Euroscreen is a dual platform company developing assays and screening technologies for the discovery of drugs acting on G protein-coupled receptors (GPCRs) and a pipeline of drug candidates that act on GPCRs. Founded in 1994 by leading experts in the field of GPCRs, Euroscreen has always been recognized as one of the reference providers of GPCR science. Following pioneering work in GPCR discovery and science, the Company focused its efforts on the discovery of new GPCRs, and now direct our prim...

more>>